Clinical characteristics of patients with primary cutaneous large B-cell lymphoma
Case no. . | Clinical presentation . | Sex (age at diagnosis, y) . | Initial therapy . | Result of initial therapy . | Relapse . | Follow-up status, (period, mo) . |
|---|---|---|---|---|---|---|
| PCFCCL | ||||||
| 1 | Multiple tumors on the scalp | M (76) | RT | CR | None | D- (36) |
| 2 | Localized tumors on the chest | M (38) | RT | CR | None | A- (192) |
| 3 | Localized plaques and tumors on the back | M (62) | RT | CR | Skin + EC | D- (41) |
| 4 | Grouped plaques and tumors on the scalp | M (61) | RT | CR | Skin | A- (109) |
| 5 | Solitary tumor on the scalp | F (69) | RT | CR | None | A- (127) |
| 6 | Solitary tumor on the scalp | M (37) | RT | CR | Skin | A- (68) |
| 7 | Grouped plaques and tumors on the chest | F (50) | RT | CR | None | A- (24) |
| 8 | Solitary tumor on the scalp | M (55) | RT | CR | None | A- (8) |
| PCLBCL-leg | ||||||
| 9 | Tumors on right cheek and right upper leg | M (69) | CHOP | CR | Skin + EC | D+ (35) |
| 10 | 3 tumors on left lower leg | M (47) | CHOP | CR | None | A- (32) |
| 11 | Multiple tumors on right lower leg | F (84) | CHOP | CR | Skin | A- (30) |
| 12 | 2 tumors on left lower leg | F (74) | CHOP | CR | None | A- (30) |
| 13 | Solitary tumor on lower leg | F (62) | RT | CR | None | D- (36) |
| 14 | Multiple tumors on left lower leg | M (89) | CHOP | CR | Skin + EC | D+ (12) |
| 15 | Multiple tumors on left lower leg | F (90) | PUVA-phototherapy | PR | Skin + EC | D+ (29) |
| 16 | Solitary tumor on left lower leg | F (88) | RT | CR | Skin + EC | D+ (26) |
| 17 | Tumors and plaque on right lower leg | F (77) | RT | CR | Skin | A- (45) |
| 18 | Solitary tumor on left lower leg | F (83) | RT | CR | EC | D+ (24) |
| 19 | Multiple tumors on both legs | F (76) | CHOP | CR | Skin | D- (11) |
| 20 | Multiple tumors on both lower legs | F (75) | CHOP | CR | None | A- (12) |
| 21 | Solitary tumor on right lower leg | F (75) | RT | CR | Skin + EC | D+ (73) |
Case no. . | Clinical presentation . | Sex (age at diagnosis, y) . | Initial therapy . | Result of initial therapy . | Relapse . | Follow-up status, (period, mo) . |
|---|---|---|---|---|---|---|
| PCFCCL | ||||||
| 1 | Multiple tumors on the scalp | M (76) | RT | CR | None | D- (36) |
| 2 | Localized tumors on the chest | M (38) | RT | CR | None | A- (192) |
| 3 | Localized plaques and tumors on the back | M (62) | RT | CR | Skin + EC | D- (41) |
| 4 | Grouped plaques and tumors on the scalp | M (61) | RT | CR | Skin | A- (109) |
| 5 | Solitary tumor on the scalp | F (69) | RT | CR | None | A- (127) |
| 6 | Solitary tumor on the scalp | M (37) | RT | CR | Skin | A- (68) |
| 7 | Grouped plaques and tumors on the chest | F (50) | RT | CR | None | A- (24) |
| 8 | Solitary tumor on the scalp | M (55) | RT | CR | None | A- (8) |
| PCLBCL-leg | ||||||
| 9 | Tumors on right cheek and right upper leg | M (69) | CHOP | CR | Skin + EC | D+ (35) |
| 10 | 3 tumors on left lower leg | M (47) | CHOP | CR | None | A- (32) |
| 11 | Multiple tumors on right lower leg | F (84) | CHOP | CR | Skin | A- (30) |
| 12 | 2 tumors on left lower leg | F (74) | CHOP | CR | None | A- (30) |
| 13 | Solitary tumor on lower leg | F (62) | RT | CR | None | D- (36) |
| 14 | Multiple tumors on left lower leg | M (89) | CHOP | CR | Skin + EC | D+ (12) |
| 15 | Multiple tumors on left lower leg | F (90) | PUVA-phototherapy | PR | Skin + EC | D+ (29) |
| 16 | Solitary tumor on left lower leg | F (88) | RT | CR | Skin + EC | D+ (26) |
| 17 | Tumors and plaque on right lower leg | F (77) | RT | CR | Skin | A- (45) |
| 18 | Solitary tumor on left lower leg | F (83) | RT | CR | EC | D+ (24) |
| 19 | Multiple tumors on both legs | F (76) | CHOP | CR | Skin | D- (11) |
| 20 | Multiple tumors on both lower legs | F (75) | CHOP | CR | None | A- (12) |
| 21 | Solitary tumor on right lower leg | F (75) | RT | CR | Skin + EC | D+ (73) |
PCFCCL indicates primary cutaneous follicle center cell lymphoma; PCLBCL-leg, primary cutaneous large B-cell lymphoma of the leg; CHOP, multiagent anthracycline-based chemotherapy; RT, radiotherapy; CR, complete remission; PR, partial remission; EC, extracutaneous relapse; A -, alive with no evidence of disease; A +, alive with disease; D+, died of lymphoma; D-, died of other cause.